Insider Trading & Ownership - Worthington Mark

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Worthington Mark
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-01-05
Sale(A)
2024-02-16
4:37 pm
Athira Pharma Inc.ATHAWorthington Mark
GENERAL COUNSEL
2,412$2.91$7,01934,452
(Direct)
View
2024-01-05
Sale
2024-01-08
4:38 pm
Athira Pharma Inc.ATHAWorthington Mark
General Counsel
2,412$2.91$7,01934,452
(Direct)
View
2022-06-23
Sale
2022-06-24
7:55 pm
Athira Pharma Inc.ATHAWorthington Mark
General Counsel
2,614$2.69$7,03219,097
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-14
Option Award
2024-02-16
5:01 pm
N/A
2034-02-13
Athira Pharma Inc.ATHAWorthington Mark
GENERAL COUNSEL
220,000$0220,000
(Direct)
View
2023-05-18
Option Award(A)
2024-02-16
4:37 pm
N/A
N/A
Athira Pharma Inc.ATHAWorthington Mark
GENERAL COUNSEL
7,767$2.4134,452
(Direct)
View
2024-01-04
Option Award(A)
2024-02-16
4:37 pm
N/A
N/A
Athira Pharma Inc.ATHAWorthington Mark
GENERAL COUNSEL
10,000$034,452
(Direct)
View
2023-05-18
Option Award
2024-01-08
4:38 pm
N/A
N/A
Athira Pharma Inc.ATHAWorthington Mark
General Counsel
7,767$2.4134,452
(Direct)
View
2024-01-04
Option Award
2024-01-08
4:38 pm
N/A
N/A
Athira Pharma Inc.ATHAWorthington Mark
General Counsel
10,000$034,452
(Direct)
View
2023-01-19
Option Award
2023-01-23
5:55 pm
N/A
2033-01-18
Athira Pharma Inc.ATHAWorthington Mark
General Counsel
150,000$0150,000
(Direct)
View
2022-06-22
Option Award
2022-06-24
7:55 pm
N/A
N/A
Athira Pharma Inc.ATHAWorthington Mark
General Counsel
10,000$019,097
(Direct)
View
2022-05-18
Option Award
2022-06-24
7:55 pm
N/A
N/A
Athira Pharma Inc.ATHAWorthington Mark
General Counsel
3,396$7.0619,097
(Direct)
View
2022-01-18
Option Award
2022-01-20
5:27 pm
N/A
2032-01-17
Athira Pharma Inc.ATHAWorthington Mark
General Counsel
150,000$0150,000
(Direct)
View
2021-11-03
Option Award
2021-11-05
5:03 pm
N/A
2031-11-02
Athira Pharma Inc.ATHAWorthington Mark
General Counsel
150,000$0150,000
(Direct)
View

Ownership
2021-06-01
6:32 pm
N/A
N/A
Athira Pharma Inc.ATHAWorthington Mark
General Counsel
0$08,315
(Direct)
View
(A) Indicate amendment filing.